Plasma transfusion strategies for critically ill patients

Area of Science:

• Critical Care Medicine
• Transfusion Medicine
• Evidence-Based Medicine

Background:

• Plasma transfusions are common in critically ill patients but often lack supporting evidence.
• Plasma transfusions may not correct mild coagulation abnormalities (e.g., INR) and can be linked to worse outcomes in non-massively bleeding patients.
• Current guidelines suggest limiting plasma transfusions to actively bleeding patients with abnormal coagulation tests.

Purpose of the Study:

• To evaluate the impact of restrictive versus liberal plasma transfusion thresholds on mortality and morbidity in critically ill patients.
• To assess the clinical effects of varying plasma transfusion thresholds in critical care settings.

Main Methods:

• A comprehensive literature search was conducted across multiple databases (Cochrane, MEDLINE, EMBASE) and trial registries up to August 2013.
• Included were randomized clinical trials comparing restrictive and liberal plasma transfusion strategies based on coagulation test thresholds.
• Data extraction and quality assessment were performed independently by two review authors following Cochrane Handbook guidelines.

Main Results:

• The systematic search identified 843 references.
• None of the retrieved studies met the predefined inclusion criteria for this review.
• Consequently, no trials were included in the final analysis.

Conclusions:

• There is a significant lack of evidence to guide plasma transfusion practices in critically ill patients.
• Randomized controlled trials are urgently required to establish optimal plasma transfusion strategies.
• Further research is essential to improve patient care and outcomes related to plasma transfusions.